1. Home
  2. CORT vs CACI Comparison

CORT vs CACI Comparison

Compare CORT & CACI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • CACI
  • Stock Information
  • Founded
  • CORT 1998
  • CACI 1962
  • Country
  • CORT United States
  • CACI United States
  • Employees
  • CORT N/A
  • CACI N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • CACI EDP Services
  • Sector
  • CORT Health Care
  • CACI Technology
  • Exchange
  • CORT Nasdaq
  • CACI Nasdaq
  • Market Cap
  • CORT 7.5B
  • CACI 9.7B
  • IPO Year
  • CORT N/A
  • CACI 1979
  • Fundamental
  • Price
  • CORT $71.34
  • CACI $488.18
  • Analyst Decision
  • CORT Strong Buy
  • CACI Strong Buy
  • Analyst Count
  • CORT 4
  • CACI 14
  • Target Price
  • CORT $142.00
  • CACI $508.46
  • AVG Volume (30 Days)
  • CORT 1.6M
  • CACI 246.8K
  • Earning Date
  • CORT 07-28-2025
  • CACI 08-06-2025
  • Dividend Yield
  • CORT N/A
  • CACI N/A
  • EPS Growth
  • CORT 8.36
  • CACI 22.32
  • EPS
  • CORT 1.14
  • CACI 21.19
  • Revenue
  • CORT $685,446,000.00
  • CACI $8,361,975,000.00
  • Revenue This Year
  • CORT $35.83
  • CACI $14.60
  • Revenue Next Year
  • CORT $35.24
  • CACI $7.33
  • P/E Ratio
  • CORT $62.45
  • CACI $22.99
  • Revenue Growth
  • CORT 30.93
  • CACI 14.16
  • 52 Week Low
  • CORT $29.42
  • CACI $318.60
  • 52 Week High
  • CORT $117.33
  • CACI $588.26
  • Technical
  • Relative Strength Index (RSI)
  • CORT 47.36
  • CACI 68.83
  • Support Level
  • CORT $72.48
  • CACI $454.44
  • Resistance Level
  • CORT $75.95
  • CACI $469.13
  • Average True Range (ATR)
  • CORT 2.74
  • CACI 12.10
  • MACD
  • CORT -0.16
  • CACI 4.05
  • Stochastic Oscillator
  • CORT 31.69
  • CACI 94.75

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

Share on Social Networks: